Call Now
Request Appointment

“Narayana Nethralaya launches Indigenous Gene Therapy Trials For The First Time In India” 26-7-2023

Narayana Nethralaya is proud to be the first in the world to conduct a research utilising AI and Biomarkers in predicting the conjunctivitis severity. This AI driven research has highlighted that people who are more prone to allergies or asthma showing high IgE levels and have low vitamin D levels are the ones who are severely affected. The AI model has demonstrated 97% accuracy, affirming its successful interpretation. This research will assist clinicians in delivering more personalized treatment for patients.